Published in Adolesc Med Clin on June 01, 2004
Predictors of using a microbicide-like product among adolescent girls. J Adolesc Health (2007) 1.08
Strategies for fostering HPV vaccine acceptance. Infect Dis Obstet Gynecol (2006) 0.97
Sexual health in art and science. Emerg Infect Dis (2006) 0.95
Qualitative Analysis of Sexually Experienced Female Adolescents: Attitudes about Vaginal Health. J Pediatr Adolesc Gynecol (2016) 0.91
Adolescents and Their Parents Differ on Descriptions of a Reproductive Health Study. J Pediatr Adolesc Gynecol (2015) 0.77
Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt) (2009) 2.54
Religion/spirituality and adolescent health outcomes: a review. J Adolesc Health (2006) 2.37
Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol (2008) 2.36
Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine (2006) 2.32
Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS (2003) 2.15
Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics (2009) 2.10
Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health (2005) 2.00
Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females. J Adolesc Health (2010) 1.84
Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls. Clin Infect Dis (2004) 1.79
Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev (2009) 1.74
Psychological, behavioral, and interpersonal impact of human papillomavirus and Pap test results. J Womens Health (Larchmt) (2005) 1.68
Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr (2007) 1.66
Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax. Infect Immun (2006) 1.59
Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women. BMC Womens Health (2010) 1.51
Use of complementary and alternative medicine for the treatment of genital herpes. Herpes (2005) 1.48
Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis (2003) 1.48
Vaccination: an opportunity to enhance early adolescent preventative services. J Adolesc Health (2006) 1.43
Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr (Phila) (2009) 1.43
Stability and predictors of health-related quality of life of inner-city girls. J Dev Behav Pediatr (2003) 1.41
High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides. Sex Transm Dis (2009) 1.38
Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics (2002) 1.38
Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model. Infect Immun (2007) 1.37
Mental health issues in adolescents and young adults with type 1 diabetes: prevalence and impact on glycemic control. Clin Pediatr (Phila) (2012) 1.32
Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs. J Infect Dis (2003) 1.28
Adolescent immunizations: a position paper of the Society for Adolescent Medicine. J Adolesc Health (2006) 1.28
Challenges to vaccinating adolescents: vaccine implementation issues. Pediatr Infect Dis J (2005) 1.27
Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine. J Adolesc Health (2007) 1.26
The impact of adolescent spirituality on depressive symptoms and health risk behaviors. J Adolesc Health (2005) 1.26
Personal meaning of human papillomavirus and Pap test results in adolescent and young adult women. Health Psychol (2007) 1.25
Literature review of human papillomavirus vaccine acceptability among women over 26 years. Vaccine (2009) 1.25
Perspectives on decision making about human papillomavirus vaccination among 11- to 12-year-old girls and their mothers. Clin Pediatr (Phila) (2012) 1.21
Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med (2012) 1.21
Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection. J Virol (2002) 1.19
Comparison of adolescent and young adult self-collected and clinician-collected samples for human papillomavirus. Obstet Gynecol (2004) 1.18
Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination. J Infect Dis (2005) 1.17
Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine. Clin Infect Dis (2005) 1.16
Religious/Spiritual coping in adolescents with sickle cell disease: a pilot study. J Pediatr Hematol Oncol (2009) 1.15
Entry of inflammatory cells into the mouse vagina following application of candidate microbicides: comparison of detergent-based and sulfated polymer-based agents. Sex Transm Dis (2002) 1.15
Application of optical coherence tomography for monitoring changes in cervicovaginal epithelial morphology in macaques: potential for assessment of microbicide safety. Sex Transm Dis (2008) 1.13
Adolescents' descriptions of the physical characteristics of microbicide surrogates and experiences of use. J Womens Health (Larchmt) (2006) 1.10
Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents. Pediatrics (2014) 1.09
Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected. J Infect Dis (2005) 1.08
Predictors of using a microbicide-like product among adolescent girls. J Adolesc Health (2007) 1.08
A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr (2010) 1.07
Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolesc Health (2007) 1.07
Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women. J Clin Virol (2009) 1.05
Parental acceptance of adolescent vaccines within school-based health centres. Herpes (2005) 1.04
VivaGel (SPL7013 Gel): a candidate dendrimer--microbicide for the prevention of HIV and HSV infection. Int J Nanomedicine (2007) 1.04
HPV vaccine and males: issues and challenges. Gynecol Oncol (2010) 1.03
The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women. J Pediatr (2002) 1.02
Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women. Sex Transm Dis (2010) 1.00
Progress in vaccines for sexually transmitted diseases. Infect Dis Clin North Am (2005) 0.98
Perceptions of reimbursement for clinical trial participation. J Empir Res Hum Res Ethics (2011) 0.98
Adolescent males and human papillomavirus: psychosexual development, infection, and vaccination. J Adolesc Health (2010) 0.97
Efficacy and toxicity of zinc salts as candidate topical microbicides against vaginal herpes simplex virus type 2 infection. Antimicrob Agents Chemother (2005) 0.97
Measurement of religiosity/spirituality in adolescent health outcomes research: trends and recommendations. J Relig Health (2010) 0.97
Attitudes and decision making about neonatal male circumcision in a Hispanic population in New York City. Clin Pediatr (Phila) (2012) 0.96
Spirituality and religiosity in urban adolescents with asthma. J Relig Health (2012) 0.94
Predictors of sexual satisfaction in an adolescent and college population. J Pediatr Adolesc Gynecol (2007) 0.94
Measurement of microbicide acceptability among U.S. adolescent girls. Sex Transm Dis (2007) 0.94
Parental influences on adolescent sexual behaviors. Adolesc Med State Art Rev (2007) 0.93
Racial/ethnic differences in patterns of sexual behavior and STI risk among sexually experienced adolescent girls. J Pediatr Adolesc Gynecol (2009) 0.93
Human papillomavirus vaccine decision-making in Da Nang, Vietnam: perceived spousal and adolescent-parent concordance. Vaccine (2009) 0.92
Current thinking on genital herpes. Curr Opin Infect Dis (2014) 0.92
Attitudes of men in an Australian male tolerance study towards microbicide use. Sex Health (2008) 0.91
Optical coherence tomography compared with colposcopy for assessment of vaginal epithelial damage: a randomized controlled trial. Obstet Gynecol (2011) 0.91
Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults. Sex Transm Dis (2004) 0.91
Adolescent girls' communication with "mothers" about topical microbicides. J Pediatr Adolesc Gynecol (2006) 0.91
Difficult issues in mentoring: recommendations on making the "undiscussable" discussable. Acad Med (2011) 0.91
Topical microbicide use by adolescent girls: concerns about timing, efficacy, and safety. Sex Transm Dis (2003) 0.90
Modification of primary and recurrent genital herpes in guinea pigs by passive immunization. J Gen Virol (2002) 0.90
Neonatal herpes should be a reportable disease. Sex Transm Dis (2005) 0.89
Male partners of young women: assessing their attitudes toward topical microbicides. J Adolesc Health (2008) 0.89
Conducting research on sensitive topics with adolescents: ethical and developmental considerations. J Dev Behav Pediatr (2005) 0.89
Adolescents' reasons for using a microbicide-like product over time. Int J STD AIDS (2008) 0.88
Adolescent girls perceptions of the timing of their sexual initiation: "too young" or "just right"? J Adolesc Health (2004) 0.88
Factors impacting HPV vaccination: lessons for health care professionals. Expert Rev Vaccines (2014) 0.88
Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes? Sex Transm Dis (2003) 0.88
Research on adolescents and microbicides: a review. J Pediatr Adolesc Gynecol (2009) 0.88
Human papillomavirus vaccine acceptability among a national sample of adult women in the USA. Sex Health (2010) 0.87
Relationship context associated with microbicide-like product use. J Pediatr Adolesc Gynecol (2009) 0.87
Adult women's attitudes toward the HPV vaccine. J Womens Health (Larchmt) (2010) 0.86
Human papillomavirus vaccine communication: perspectives of 11-12 year-old girls, mothers, and clinicians. Vaccine (2013) 0.86
Coercive sexual experiences and subsequent human papillomavirus infection and squamous intraepithelial lesions in adolescent and young adult women. J Adolesc Health (2005) 0.86
Adolescent issues associated with knowledge of and access to topical microbicides. J Womens Health (Larchmt) (2004) 0.86
Enrolment of young adolescents in a microbicide acceptability study. Sex Transm Infect (2009) 0.86
Influence of patient's relationship status and HPV history on physicians' decisions to recommend HPV vaccination. Vaccine (2010) 0.85
Benzalkonium chloride causes colposcopic changes and increased susceptibility to genital herpes infection in mice. Sex Transm Dis (2010) 0.85